NXXI Incorporated operates in the Biological products exc. diagnostic sector. NXXI Inc., formerly Nutrition 21, Inc., is a nutritional bioscience company. The Company primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party, non-end users to be further fabricated, blended or packaged for sales to end-users as nutritional supplements or otherwise. It holds more than 30 patents for nutrition products and their uses. The Company conducted its business through one segment, the Ingredients Segment. On November 22, 2011, the Company together with its wholly owned subsidiaries (the Debtors) completed the sale, whereupon N21 Acquisition Holding, LLC (the Purchaser) acquired all of the rights, title and interests in and to substantially all of the Debtors' assets, including the Nutrition 21 trade name. The Company will continue to operate as Nutrition 21. In
our complete report available for purchase the company is compared to: Osiris Therapeutics, Inc., Nabi Biopharmaceuticals and Idera Pharmaceuticals, Inc..